Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Autologous hematopoietic stem cell transplantation in combination with immunoablative protocol in secondary progressive multiple sclerosis--A 10-year follow-up of the first transplanted patient.
Cognitive performance, fatigue and event-related potentials in patients with clinically isolated syndrome.
Nanocarriers as Tools in Delivering Active Compounds for Immune System Related Pathologies.
Quality of life in relapsing-remitting multiple sclerosis patients receiving CinnoVex compared with Avonex.
Reprogramming A375 cells to induced‑resembled neuronal cells by structured overexpression of specific transcription genes.
Special Issue: Myelin Repair.
Tamoxifen: an FDA approved drug with neuroprotective effects for spinal cord injury recovery.
Assessment of severity of neurogenic bowel dysfunction in chronic patients with a simple 1-item questionnaire (PGI-S).
Comment on Paraparetic Guillain-Barré syndrome: non-demyelinating reversible conduction failure restricted to the lower limbs.
Self-reported levels of education and disability progression in multiple sclerosis.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
Urban traffic-derived nanoparticulate matter reduces neurite outgrowth via TNFα in vitro.
Natalizumab versus fingolimod in patients with relapsing-remitting multiple sclerosis non-responding to first-line injectable therapies.
APE1/Ref-1 facilitates recovery of gray and white matter and neurological function after mild stroke injury.
Loss of Hippocampal Oligodendrocytes Contributes to the Deficit of Contextual Fear Learning in Adult Rats Experiencing Early Bisphenol A Exposure.
Discovery and structural optimization of 4-(4-(benzyloxy)phenyl)-3,4-dihydropyrimidin-2(1H)-ones as RORc inverse agonists.
Assessment of the myelin water fraction in rodent spinal cord using T2-prepared ultrashort echo time MRI.
Pathophysiological Concepts in Multiple Sclerosis and the Therapeutic Effects of Hydrogen Sulfide.
Influenza vaccination in patients with multiple sclerosis is possible with some considerations.
Enhancement of aptamer immobilization using egg shell-derived nano-sized spherical hydroxyapatite for thrombin detection in neuroclinic.
Predictors of the 10-year direct costs for treating multiple sclerosis.
Quantitative analysis of multiple sclerosis patients' preferences for drug treatment: a best-worst scaling study.
Insulin influenced expression of myelin proteins in diabetic peripheral neuropathy.
γδ T Cells and NK Cells - Distinct Pathogenic Roles as Innate-Like Immune Cells in CNS Autoimmunity.
Germinoma Mimicking Tumefactive Demyelinating Disease in Pediatric Patients.
Pages
« first
‹ previous
…
835
836
837
838
839
840
841
842
843
…
next ›
last »